Patents by Inventor Yoonsung SONG

Yoonsung SONG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220409598
    Abstract: Methods of treating a subject with diabetes or pre-diabetes include administering an effective amount of a phenyl propionic acid of the Formula (I), an isomer, or a pharmaceutically acceptable salt thereof to the subject to lower one or more of HbA1c level, fasting plasma glucose level, 2-hour oral glucose tolerance test (OGTT) result level, and random plasma glucose level.
    Type: Application
    Filed: June 17, 2022
    Publication date: December 29, 2022
    Applicant: ILDONG PHARMACEUTICAL CO., LTD.
    Inventors: Jong Min YOON, Don-Gil Lee, In-Gyu Je, YoonSung Song, JunGu Park, Soo Yong Chung, Jung Ho Kim, Yearin Jun
  • Patent number: 10709793
    Abstract: Disclosed is a gene/carrier complex for preventing or treating inflammatory diseases, including tumor necrosis factor-? converting enzyme (TNF-? converting enzyme, TACE) shRNA and a nonviral gene carrier, wherein the nonviral gene carrier includes an acetate of disulfide-linked poly(oligo-arginine) or a TFA salt of poly(oligo-aspartic acid)poly(oligo-arginine).
    Type: Grant
    Filed: November 2, 2018
    Date of Patent: July 14, 2020
    Assignees: INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY, INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS
    Inventors: Yong-Hee Kim, Tae-Hwan Kim, Chul-Su Yang, Yoonsung Song, Jee-Young Chung, Sungsin Jo, So Mi Kim, Qurrat Ui Ain, Ye-Ram Kim
  • Publication number: 20190054180
    Abstract: Disclosed is a gene/carrier complex for preventing or treating inflammatory diseases, including tumor necrosis factor-? converting enzyme (TNF-? converting enzyme, TACE) shRNA and a nonviral gene carrier, wherein the nonviral gene carrier includes an acetate of disulfide-linked poly(oligo-arginine) or a TFA salt of poly(oligo-aspartic acid)poly(oligo-arginine).
    Type: Application
    Filed: November 2, 2018
    Publication date: February 21, 2019
    Inventors: Yong-Hee KIM, Tae-Hwan KIM, Chul-Su YANG, Yoonsung SONG, Jee-Young CHUNG, Sungsin JO, So Mi KIM, Qurrat Ul AIN, Ye-Ram KIM
  • Publication number: 20180193474
    Abstract: Disclosed is a gene/carrier complex for preventing or treating inflammatory diseases, including tumor necrosis factor-? converting enzyme (TNF-? converting enzyme, TACE) shRNA and a nonviral gene carrier, wherein the nonviral gene carrier includes an acetate of disulfide-linked poly(oligo-arginine) or a TFA salt of poly(oligo-aspartic acid)poly(oligo-arginine).
    Type: Application
    Filed: September 29, 2017
    Publication date: July 12, 2018
    Inventors: Yong-Hee KIM, Chul-Su YANG, Yoonsung SONG, So Mi KIM, Ye-Ram KIM, Jee-Young CHUNG, Qurrat UI AIN